Hot off the Press !! 📣📰💪
Porsolt is proud to announce our most recent publication in #Cancers journal, focusing on potential treatments for Glioblastoma. The paper entitled ”Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models” evaluated potential treatments in both in vitro and in vivo models.
Gliomas and Glioblastomas accounting for 50% of primary brain tumors, and there is a need to discover potential therapies that can prolong the lives of patients.
Here is a direct link to the paper: https://lnkd.in/dJUaiPQq
Please feel free to contact us to learn more about our expertise in preclinical Oncology research, or any of our many other areas of expertise and capabilities.